Document Detail

Prostate brachytherapy in patients with median lobe hyperplasia.
MedLine Citation:
PMID:  10900427     Owner:  NLM     Status:  MEDLINE    
Our aim was to document the technical and clinical course of prostate brachytherapy patients with radiographic evidence of median lobe hyperplasia (MLH). Eight patients with MLH were identified during our routine brachytherapy practice, representing 9% of the 87 brachytherapy patients treated during a 6-month period. No effort was made to avoid brachytherapy in patients noted to have MLH on diagnostic work-up. Cystoscopic evaluation was not routinely performed. Postimplant axial computed tomographic (CT) images of the prostate were obtained at 0.5 cm intervals. Preimplant urinary obstructive symptoms were quantified by the criteria of the American Urologic Association (AUA). Each patient was contacted during the writing of this report to update postimplant morbidity information. There was no apparent association between the degree of MLH and preimplant prostate volume or AUA score. Intraoperatively, we were able to visualize MLH by transrectal ultrasound and did not notice any particular difficulty placing sources in the MLH tissue or migration of sources out of the tissue. The prescription isodose covered from 81% to 99% of the postimplant CT-defined target volume, achieving adequate dose to the median lobe tissue in all patients. Two of the eight patients developed acute, postimplant urinary retention. The first patient required intermittent self-catheterization for 3 months and then resumed spontaneous urination. MLH does not appear to be a strong contraindication to prostate brachytherapy, and prophylactic resection of hypertrophic tissue in such patients is probably not warranted. Int. J. Cancer (Radiat. Oncol. Invest.) 90, 152-156 (2000).
K Wallner; S Smathers; S Sutlief; J Corman; W Ellis
Related Documents :
21302137 - Bleeding lesions within reach of conventional endoscopy in capsule endoscopy examinatio...
6857457 - Monitoring of patients with carcinoma of the large intestine by use of acute phase prot...
1986477 - Anal submucosal injection: a new route for drug administration. vi. chronic prostatitis...
17602307 - Rising psa in patients with minor luts without evidence of prostatic carcinoma: a missi...
11473327 - Right-sided shift found in metachronous colorectal adenomas.
10500947 - Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  90     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-08-03     Completed Date:  2000-08-03     Revised Date:  2007-07-24    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  152-6     Citation Subset:  IM    
Copyright Information:
Copyright 2000 Wiley-Liss, Inc.
Department of Radiation Oncology, Puget Sound Health Care System, Seattle, Washington, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Middle Aged
Prostatic Hyperplasia / radiotherapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Results of linear accelerator-based stereotactic radiosurgery for recurrent and newly diagnosed acou...
Next Document:  Stereotactic radiosurgery for brain metastases: results and prognostic factors.